The risk of recurrence of a thrombotic event in patients with APS is greatly increased in those who have multiple subtypes of aPL (LA, aCL, anti-β2-GPI, aPS/PT), i.e., double, triple positive patients. Here, FASLG is linked to autoimmune polyendocrinopathy.